<SEC-DOCUMENT>0000882104-20-000018-index.html : 20200228
<SEC-HEADER>0000882104-20-000018.hdr.sgml : 20200228
<ACCEPTANCE-DATETIME>20200228081740
ACCESSION NUMBER:		0000882104-20-000018
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20200228
DATE AS OF CHANGE:		20200228
EFFECTIVENESS DATE:		20200228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PDL BIOPHARMA, INC.
		CENTRAL INDEX KEY:			0000882104
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943023969
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19756
		FILM NUMBER:		20665725

	BUSINESS ADDRESS:	
		STREET 1:		932 SOUTHWOOD BLVD
		CITY:			INCLINE VILLAGE
		STATE:			NV
		ZIP:			89451
		BUSINESS PHONE:		775-832-8500

	MAIL ADDRESS:	
		STREET 1:		932 SOUTHWOOD BLVD
		CITY:			INCLINE VILLAGE
		STATE:			NV
		ZIP:			89451

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROTEIN DESIGN LABS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>pdli-20200228defa14adoc.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: pdli-20200228defa14adoc.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>pdli-20200228ex101.htm
<DESCRIPTION>COOPERATION AGREEMENT
<TEXT>
Document 2 - file: pdli-20200228ex101.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>pdli-20200228ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
Document 3 - file: pdli-20200228ex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pdllogo2a09.jpg
<TEXT>
Document 4 - file: pdllogo2a09.jpg

</DOCUMENT>
</SEC-DOCUMENT>